Update on viral infections in immunocompromised patients;Actualización de las infecciones víricas en los pacientes con inmunosupresión

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 25, Issue SUPPL. 1, 2007, Pages 2-11

  De La Cámara, Rafael ^a   López Jiménez, Javier ^b   Vallejo, Carlos ^c   Vázquez, Lourdes ^d   Luis Pérez, José ^e   Varo, Evaristo ^f   Madero, Luis ^g   Mensa, José ^h  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f University Hospital of Santiago de Compostela   (Spain)

^g HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

Adoptive specific cellular immunotherapy; CMV; Community acquired respiratory viruses; Herpes simplex virus; Herpesvirus; Human metapneumovirus; Human T cell leukaemia virus type I; Immunocompromised patients; Influenza; Solid organ transplants; Stem cell hematopoietic transplants; Viral infections

Indexed keywords

ACICLOVIR; AMANTADINE; ANTIVIRUS AGENT; DEHYDROXYMETHYLEPOXYQUINOMICIN; ELTAMIVIR; GANCICLOVIR; INFLUENZA VACCINE; ITRACONAZOLE; OSELTAMIVIR; PLACEBO; RIMANTADINE; UNCLASSIFIED DRUG; ZANAMIVIR;

ADOPTIVE IMMUNOTHERAPY; ANTIVIRAL RESISTANCE; ASPERGILLOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALOVIRUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A; META ANALYSIS; METAPNEUMOVIRUS; MORTALITY; MYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PNEUMONIA; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; REVIEW; SYSTEMATIC REVIEW;

EID: 66749084359     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(07)75787-7     Document Type: Article

References (47)

1. P. Ljungman, P. Reusser, R. De la Camara, H. Einsele, D. Engelhard, and P. Ribaud Management of CMV infections: recommendations from the infectious diseases working party of the EBMT Bone Marrow Transplant 33 2004 1075 1081 (Pubitemid 38786496)
2. B.C. Fries, S.R. Riddell, H.W. Kim, L. Corey, C. Dahlgren, and A. Woolfrey Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation Biol Blood Marrow Transplant 11 2005 136 148 (Pubitemid 40186211)
3. A.C. Kalil, J. Levitsky, E. Lyden, J. Stoner, and A.G. Freifeld Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients Ann Intern Med 143 2005 870 880 (Pubitemid 46202222)
4. W.G. Nichols, K.A. Guthrie, L. Corey, and M. Boeckh Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy Clin Infect Dis 39 2004 1300 1306 (Pubitemid 39458515)
5. J.V. Williams, R. Martino, N. Rabella, M. Otegui, R. Parody, and J.M. Heck A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections J Infect Dis 192 2005 1061 1065 (Pubitemid 41266804)
6. D.M. Zerr, L. Corey, H.W. Kim, M.L. Huang, L. Nguy, and M. Boeckh Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation Clin Infect Dis 40 2005 932 940 (Pubitemid 40418297)
7. C. Danve-Szatanek, M. Aymard, D. Thouvenot, F. Morfin, G. Agius, and I. Bertin Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up J Clin Microbiol 42 2004 242 249 (Pubitemid 38082727)
8. M. Watanabe, T. Ohsugi, M. Shoda, T. Ishida, S. Aizawa, and M. Maruyama-Nagai Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia Blood 106 2005 2462 2471 (Pubitemid 41510821)
9. K. Perruccio, A. Tosti, E. Burchielli, F. Topini, L. Ruggeri, and A. Carotti Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation Blood 106 2005 4397 4406 (Pubitemid 41775954)
10. P. Ljungman, P. Griffiths, and C. Paya Definitions of cytomegalovirus infection and disease in transplant recipients Clin Infect Dis 34 2002 1094 1097 (Pubitemid 34289682)
11. N. Singh Interactions between viruses in transplant recipients Clin Infect Dis 40 2005 430 436 (Pubitemid 40216513)
12. M. Boeckh, and W.G. Nichols Immunosuppressive effects of beta-herpesviruses Herpes 10 2003 12 16 (Pubitemid 37486595)
13. A.E. Broers, R. Van Der Holt, J.W. Van Esser, J.W. Gratama, S. Henzen-Logmans, and V. Kuenen-Boumeester Increased transplant-related morbidity and mortality in CMV- seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation Blood 95 2000 2240 2245 (Pubitemid 30167720)
14. N. Kroger, T. Zabelina, W. Kruger, H. Renges, N. Stute, and J. Schrum Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin Br J Haematol 113 2001 1060 1071 (Pubitemid 32634777)
15. W.G. Nichols, L. Corey, T. Gooley, C. Davis, and M. Boeckh High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection J Infect Dis 185 2002 273 282 (Pubitemid 34107239)
16. K.A. Marr, R.A. Carter, M. Boeckh, P. Martin, and L. Corey Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 100 2002 4358 4366 (Pubitemid 35429674)
17. M. Boeckh, and W.G. Nichols The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy Blood 103 2004 2003 2008 (Pubitemid 38326213)
18. W.G. Nichols, L. Corey, T. Gooley, C. Davis, and M. Boeckh Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome Blood 98 2001 573 578
19. J.R. Wingard, W.G. Nichols, and G.B. McDonald Supportive care Hematology (Am Soc Hematol Educ Program) 2004 372 389
20. P. Ljungman, K.N. Ward, B.N. Crooks, A. Parker, R. Martino, and P.J. Shaw Respiratory virus infections after stem cell transplantation. A prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Bone Marrow Transplant 28 2001 479 484 (Pubitemid 33069626)
21. P. Ljungman, R. De la Camara, N. Milpied, L. Volin, C.A. Russell, and A. Crisp Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants Blood 99 2002 3050 3056 (Pubitemid 34525398)
22. C. Gilbert, and G. Boivin Human cytomegalovirus resistance to antiviral drugs Antimicrob Agents Chemother 49 2005 873 883 (Pubitemid 40327699)
23. P. Reusser, C. Cordonnier, H. Einsele, D. Engelhard, H. Link, and A. Locasciulli European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow transplant 17 1996 813 817
24. H. Einsele, and H. Hebart CMV-specific immunotherapy Hum Immunol 65 2004 558 564 (Pubitemid 38686781)
25. S. Gottschalk, C.M. Rooney, and H.E. Heslop Post-transplant lymphoproliferative disorders Annu Rev Med 56 2005 29 44 (Pubitemid 40299772)
26. J.A. Zaia Cytomegalovirus infections E.D. Thomas K. Blume S. Forman Haematopoietic cell transplantation 2nd ed. 1999 Blackwell Science, Inc. London 560 584
27. J.R. Mera, E. Whimbey, L. Elting, A. Preti, M.A. Luna, and Bruner J.M. Cytomegalovirus pneumonia in adult nontransplantation patients with cancer: review of 20 cases occurring from 1964 through 1990 Clin-Infect-Dis 22 1996 1046 1050 (Pubitemid 26260610)
28. Q. Nguyen, E. Estey, I. Raad, K. Rolston, H. Kantarjian, and K. Jacobson Cytomegalovirus pneumonia in adults with leukemia: an emerging problem Clin Infect Dis 32 2001 539 545 (Pubitemid 32564993)
29. K.A. Thursky, L.J. Worth, J.F. Seymour, H. Miles Prince, and M.A. Slavin Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab* Br J Haematol 132 2006 3 12 (Pubitemid 43381565)
30. D.A. Clark, and P.D. Griffiths Human herpesvirus 6: relevance of infection in the immunocompromised host Br J Haematol 120 2003 384 395 (Pubitemid 36241494)
31. C. Rossi, M.L. Delforge, F. Jacobs, M. Wissing, O. Pradier, and M. Remmelink Fatal primary infection due to human herpesvirus 6 variant A in a renal transplant recipient Transplantation 71 2001 288 292 (Pubitemid 32126114)
32. K. Tanaka-Taya, J. Sashihara, H. Kurahashi, K. Amo, H. Miyagawa, and K. Kondo Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA J Med Virol 73 2004 465 473 (Pubitemid 38685755)
33. T. Yoshikawa Human herpesvirus 6 infection in haematopoietic stem cell transplant patients Br J Haematol 124 2004 421 432 (Pubitemid 38230587)
34. D. Malvy, M. Treilhaud, S. Bouee, A. Crochard, D. Vallee, and A. El Hasnaoui A retrospective, case-control study of acyclovir resistance in herpes simplex virus Clin Infect Dis 41 2005 320 326 (Pubitemid 41022108)
35. F. Nugier, J.N. Colin, M. Aymard, and M. Langlois Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey J-Med-Virol 36 1992 1 12
36. P. Ljungman, D. Engelhard, R. De la Camara, H. Einsele, A. Locasciulli, and R. Martino Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT Bone Marrow Transplant 35 2005 737 746 (Pubitemid 40613780)
37. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation MMWR Morb Mortal Wkly Rep 49 2000 1 125
38. A.A. Johny, A. Clark, N. Price, D. Carrington, A. Oakhill, and D.I. Marks The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation Bone Marrow Transplant 29 2002 113 115 (Pubitemid 34144842)
39. R.A. Bright, M.J. Medina, X. Xu, G. Perez-Oronoz, T.R. Wallis, and X.M. Davis Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern Lancet 366 2005 1175 1181 (Pubitemid 41393595)
40. R.A. Bright, D.K. Shay, B. Shu, N.J. Cox, and A.I. Klimov Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States Jama 295 2006 891 894 (Pubitemid 43295823)
41. High Levels of Adamantane Resistance Among Influenza A (H3N2) Viruses and Interim Guidelines for Use of Antiviral Agents - - United States, 2005 - 06 Influenza Season. MMWR Morb Mortal Wkly Rep. 2006;55:1-125.
42. B.G. Van den Hoogen, J.C. De Jong, J. Groen, T. Kuiken, R. De Groot, and R.A. Fouchier A newly discovered human pneumovirus isolated from young children with respiratory tract disease Nat Med 7 2001 719 724 (Pubitemid 32588029)
43. M.E. Hamelin, Y. Abed, and G. Boivin Human metapneumovirus: a new player among respiratory viruses Clin Infect Dis 38 2004 983 990 (Pubitemid 38457207)
44. P.A. Cane, B.G. Van Den Hoogen, S. Chakrabarti, C.D. Fegan, and A.D. Osterhaus Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease Bone Marrow Transplant 31 2003 309 310 (Pubitemid 36336237)
45. M. Shuh, and M. Beilke The human T-cell leukemia virus type 1 (HTLV-1): New insights into the clinical aspects and molecular pathogenesis of adult t-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM) Microsc Res Tech 68 2005 176 196 (Pubitemid 41696968)
46. H. Hebart, C. Bollinger, P. Fisch, J. Sarfati, C. Meisner, and M. Baur Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies Blood 100 2002 4521 4528 (Pubitemid 35429693)
47. S. Shoham, and S.M. Levitz The immune response to fungal infections Br J Haematol 129 2005 569 582 (Pubitemid 40825818)